<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang Y</submitter><funding>Wuhan Science and Technology Project</funding><funding>National Natural Science Foundation of Hubei</funding><funding>Doctoral Start-up Foundation of Hubei University of Technology</funding><funding>National Natural Science Foundation of China</funding><pagination>168</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10968549</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(3)</volume><pubmed_abstract>Transient receptor potential vanilloid-6 (TRPV6) is a cation channel belonging to the TRP superfamily, specifically the vanilloid subfamily, and is the sixth member of this subfamily. Its presence in the body is primarily limited to the skin, ovaries, kidney, testes, and digestive tract epithelium. The body maintains calcium homeostasis using the TRPV6 channel, which has a greater calcium selectivity than the other TRP channels. Several pieces of evidence suggest that it is upregulated in the advanced stages of thyroid, ovarian, breast, colon, and prostate cancers. The function of TRPV6 in regulating calcium signaling in cancer will be covered in this review, along with its potential applications as a cancer treatment target.</pubmed_abstract><journal>Biology</journal><pubmed_title>The TRPV6 Calcium Channel and Its Relationship with Cancer.</pubmed_title><pmcid>PMC10968549</pmcid><funding_grant_id>2022020801020272</funding_grant_id><funding_grant_id>2019020701011475</funding_grant_id><funding_grant_id>2020CFB413</funding_grant_id><funding_grant_id>82273970</funding_grant_id><funding_grant_id>2022EHB038</funding_grant_id><funding_grant_id>BSQD2020035</funding_grant_id><funding_grant_id>31871176</funding_grant_id><funding_grant_id>32070726</funding_grant_id><funding_grant_id>2020CFA073</funding_grant_id><funding_grant_id>XJ2021001007</funding_grant_id><funding_grant_id>32270768</funding_grant_id><pubmed_authors>Tang J</pubmed_authors><pubmed_authors>Zhou C</pubmed_authors><pubmed_authors>Lyu H</pubmed_authors><pubmed_authors>Ali DW</pubmed_authors><pubmed_authors>Michalak M</pubmed_authors><pubmed_authors>Guo D</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zhang R</pubmed_authors><pubmed_authors>Xiao S</pubmed_authors><pubmed_authors>Deng X</pubmed_authors><pubmed_authors>Chen XZ</pubmed_authors></additional><is_claimable>false</is_claimable><name>The TRPV6 Calcium Channel and Its Relationship with Cancer.</name><description>Transient receptor potential vanilloid-6 (TRPV6) is a cation channel belonging to the TRP superfamily, specifically the vanilloid subfamily, and is the sixth member of this subfamily. Its presence in the body is primarily limited to the skin, ovaries, kidney, testes, and digestive tract epithelium. The body maintains calcium homeostasis using the TRPV6 channel, which has a greater calcium selectivity than the other TRP channels. Several pieces of evidence suggest that it is upregulated in the advanced stages of thyroid, ovarian, breast, colon, and prostate cancers. The function of TRPV6 in regulating calcium signaling in cancer will be covered in this review, along with its potential applications as a cancer treatment target.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-21T21:27:24.979Z</modification><creation>2025-04-05T18:24:38.512Z</creation></dates><accession>S-EPMC10968549</accession><cross_references><pubmed>38534438</pubmed><doi>10.3390/biology13030168</doi></cross_references></HashMap>